.With very early phase 1 records today out in bush, metabolic disease attire Metsera is actually thr...
.Rivus Pharmaceuticals has introduced the data behind its own phase 2 obesity win in cardiac arrest ...
.Bristol Myers Squibb is actually spending Best Medicine $110 thousand upfront to establish reagents...
.Novartis has printer inked an offer potentially worth more than $1 billion with Flagship-founded Ge...
.Lately debuted Metsera is actually unfolding some phase 1 information for its own GLP-1 receptor ag...
.Among the genetic medicines branches race, Main Pioneering is unveiling a brand-new business to hel...
.BioAge Labs is actually considering about $180 million in first proceeds coming from an IPO and a p...
.An attempt through Merck & Co. to open the microsatellite stable (MSS) metastatic colorectal can...
.Spain-based Asabys Partners has closed a fund of 180 million europeans ($ 200 thousand), loan that ...
.BioAge Labs is generating almost $200 million through its Nasdaq IPO this morning, with the profits...